Dow Jones

44,722.06

-0.31%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

QTRX

Quanterix (QTRX)

Quanterix Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:QTRX

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
22/11/2024	16:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QTRX	Quanterix Corporation
22/11/2024	16:00	Business Wire	Quanterix Announces Receipt of Expected Notice from Nasdaq	NASDAQ:QTRX	Quanterix Corporation
18/11/2024	17:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QTRX	Quanterix Corporation
13/11/2024	15:01	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:QTRX	Quanterix Corporation
12/11/2024	15:01	Business Wire	Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024	NASDAQ:QTRX	Quanterix Corporation
05/11/2024	15:00	Business Wire	Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024	NASDAQ:QTRX	Quanterix Corporation
28/10/2024	15:30	Business Wire	New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer’s Disease Diagnostic Information	NASDAQ:QTRX	Quanterix Corporation
04/10/2024	06:07	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:QTRX	Quanterix Corporation
02/10/2024	15:00	Business Wire	Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors	NASDAQ:QTRX	Quanterix Corporation
30/09/2024	15:00	Business Wire	Quanterix Announces Commercialization of p-Tau 217 Test Kit	NASDAQ:QTRX	Quanterix Corporation
29/08/2024	15:00	Business Wire	Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference	NASDAQ:QTRX	Quanterix Corporation
21/08/2024	15:29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:QTRX	Quanterix Corporation
19/08/2024	15:32	Business Wire	Jeffrey Elliott Appointed to Quanterix’s Board of Directors	NASDAQ:QTRX	Quanterix Corporation
16/08/2024	05:03	IH Market News	Deutsche Bank Faces Shareholder Backlash, Bank of America Sponsors 2026 World Cup, Quanterix CEO Buys More Shares	NASDAQ:QTRX	Quanterix Corporation
08/08/2024	15:59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QTRX	Quanterix Corporation
08/08/2024	15:00	Business Wire	Quanterix Releases Financial Results for the Second Quarter of 2024	NASDAQ:QTRX	Quanterix Corporation
06/08/2024	15:00	Business Wire	Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference	NASDAQ:QTRX	Quanterix Corporation
31/07/2024	15:00	Business Wire	Quanterix To Report Second Quarter 2024 Financial Results	NASDAQ:QTRX	Quanterix Corporation
29/07/2024	07:00	Business Wire	Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217	NASDAQ:QTRX	Quanterix Corporation
17/06/2024	15:00	Business Wire	Quanterix to Participate at the Scotiabank Healthcare 1x1 Day	NASDAQ:QTRX	Quanterix Corporation
12/06/2024	16:08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:QTRX	Quanterix Corporation
05/06/2024	15:00	Business Wire	Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference	NASDAQ:QTRX	Quanterix Corporation
31/05/2024	15:01	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:QTRX	Quanterix Corporation
22/05/2024	15:00	Business Wire	Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024	NASDAQ:QTRX	Quanterix Corporation
07/05/2024	15:00	Business Wire	Quanterix Releases Financial Results for the First Quarter of 2024	NASDAQ:QTRX	Quanterix Corporation
29/04/2024	15:00	Business Wire	Quanterix To Report First Quarter 2024 Financial Results	NASDAQ:QTRX	Quanterix Corporation
21/03/2024	16:30	Business Wire	Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure	NASDAQ:QTRX	Quanterix Corporation
04/03/2024	16:27	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:QTRX	Quanterix Corporation
04/03/2024	08:00	Business Wire	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease	NASDAQ:QTRX	Quanterix Corporation
29/02/2024	15:58	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:QTRX	Quanterix Corporation